Latest News

Alexion Receives FDA Approval for ULTOMIRIS® (ravulizumab-cwvz) for Atypical Hemolytic Uremic Syndrome (aHUS)


BOSTON–(BUSINESS WIRE)–Alexion Receives FDA Approval for ULTOMIRIS® for Atypical Hemolytic Uremic Syndrome (aHUS)

Source link

Related posts

STAT Plus: Pharmalittle: China to bulk-buy to lower drug costs; Senate bill to tackle drug prices going nowhere fast

Newsemia

Study uncovers link between tube travel and spread of flu-like illnesses

Newsemia

Best Foods To Eat For People Over 50 Amid Coronavirus Pandemic

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World